Why the study?
Long-term clinical transitions from peripheral artery disease diagnosis to revascularization, major amputation, and death remained incompletely defined.
Does early revascularization (≤6 months) reduce cumulative all-cause mortality compared to no early revascularization in patients with incident peripheral artery disease across mortality risk strata?
Cohort (n=22,813)
Yes
Does early revascularization (≤6 months) reduce cumulative all-cause mortality compared to no early revascularization in patients with incident peripheral artery disease across mortality risk strata?
Multistate modeling in incident PAD reveals distinct risk profiles for limb events versus mortality and shows that early revascularization within 6 months is associated with lower 5-year mortality specifically in high-risk patients.
Background Peripheral artery disease (PAD) is characterized by heterogeneous clinical trajectories; however, long-term transitions from diagnosis to revascularization, major amputation, and death remain incompletely defined. Purpose We aimed to characterize clinical transitions in PAD using a multistate model, identify transition-specific determinants, and assess the association between early revascularization and subsequent mortality within risk strata. Methods Patients with incident PAD between 2000 and 2025 in a territory-wide multicenter cohort were included. A continuous-time multistate model was used to characterize transitions from PAD diagnosis to revascularization, major amputation, and death. State occupation probabilities were estimated, and transition-specific associations between clinical variables and each pathway were evaluated. A Cox-derived mortality risk score was categorized into tertiles for stratified analyses. IPTW-adjusted 6-month landmark analyses compared cumulative all-cause mortality between early (≤6 months) and no revascularization within 6 months across tertiles. Results A total of 22,813 patients were included (median age 77 [67–84] years; 53.9% male). Over a median follow-up of 3.3 (1.0–7.0) years, 11.1% first underwent revascularization, 6.7% first experienced major amputation, and 55.7% died without prior limb intervention. Multistate modeling demonstrated that limb events occurred predominantly early after diagnosis, whereas mortality accumulated progressively over time (Figure 1). Transition-specific analyses revealed distinct risk profiles: limb-related transitions were mainly associated with uncontrolled diabetes, tissue loss, and crural target vessel intervention, whereas mortality-related transitions were more strongly associated with older age, cardiovascular comorbidities, hypoalbuminemia, and higher neutrophil-to-lymphocyte ratio (NLR). Renal dysfunction was independently associated with both limb- and mortality-related transitions. In the 6-month landmark analysis, patients undergoing early revascularization (≤6 months) had lower 5-year cumulative mortality than those without revascularization within 6 months in the high-risk tertile (72.5% vs 78.6%; log-rank p=0.039), but not in the low- or intermediate-risk tertiles (Figure 2). Conclusion Multistate modeling delineated distinct pathways following PAD diagnosis, with limb-related transitions associated with metabolic burden and disease severity, and mortality-related transitions associated with systemic frailty, inflammation, and cardiovascular comorbidity. Renal dysfunction spanned both domains. Early revascularization was associated with lower long-term mortality in high-risk patients, suggesting the potential value of risk-stratified revascularization strategies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Peripheral artery disease (n=22,813). Early revascularization (≤6 months) vs. No revascularization within 6 months was evaluated on 5-year cumulative all-cause mortality in the high-risk tertile (p=0.039).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: